It has been hypothesized that PSA flares are due to treatment-induced cancer cell lysis and PSA release into the bloodstream [16,24], increased differentiation of prostate cancer stem cells [16], or androgen receptor activation by corticosteroid co-medication [25]. This evidence concerns the gene KLK3 and prostate cancer.